Litigation Details for SALIX PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC (D.N.J. 2024)
✉ Email this page to a colleague
SALIX PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC (D.N.J. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-04-05 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Edward S. Kiel |
| Jury Demand | Defendant | Referred To | Ann Marie Donio |
| Patents | 10,456,384; 8,193,196; 8,518,949; 8,741,904; 9,271,968 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SALIX PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SALIX PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-04-05 | 1 | of U.S. Patent Nos. 11,779,571 (“the ’571 patent”), 11,564,912 (“the ’912 patent”), 10,456,384 (“the ’…’571 patent, the ’912 patent, the ’384 patent, the ’196 patent, the ’949 patent, the ’904 patent, the…Xifaxan® patents, including the ’571 patent, the ’912 patent, the ’384 patent, the ’196 patent, the ’949…949 patent, the ’904 patent, the ’968 patent and the ’763 patent and that, in Amneal’s opinion, certain… ’384 patent”), 8,193,196 (“the ’196 patent”), 8,518,949 (“the ’949 patent”), 8,741,904 (“the ’904 patent | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
